Serological markers are associated with disease course in ulcerative colitis. A study in an unselected population-based cohort followed for 10Â years

UC patients positive for p-ANCA and possibly for ASCA may have a more unfavourable long-term disease outcome in terms of relapse than UC patients without these markers.